STAGE III ADULT HODGKIN LYMPHOMA
Clinical trials for STAGE III ADULT HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new STAGE III ADULT HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for STAGE III ADULT HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for older hodgkin patients
Disease control CompletedThis study tested a new combination treatment for older adults (age 60+) with untreated Hodgkin lymphoma. Participants received a targeted drug called brentuximab vedotin along with standard chemotherapy (AVD). The goal was to see if this approach could increase the number of pat…
Matched conditions: STAGE III ADULT HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New combo shows promise against tough lymphomas
Disease control CompletedThis study tested a combination of the drug lenalidomide with standard chemotherapy (EPOCH-R) in 55 people with aggressive B-cell lymphomas linked to the MYC gene. The goal was to find the safest dose and see how well the treatment controls the cancer. Results help guide future t…
Matched conditions: STAGE III ADULT HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC